Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

AMNEAL PHARMACEUTICALS, INC Property, Plant, and Equipment 2010-2024 | AMRX

AMNEAL PHARMACEUTICALS, INC property, plant, and equipment from 2010 to 2024. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
  
AMNEAL PHARMACEUTICALS, INC Annual Property, Plant, and Equipment
(Millions of US $)
2023 $448
2022 $470
2021 $514
2020 $478
2019 $478
2018 $544
2017 $487
2016 $233
2015 $214
2014 $188
2013 $188
2012 $181
2011 $118
2010 $106
2009 $102
AMNEAL PHARMACEUTICALS, INC Quarterly Property, Plant, and Equipment
(Millions of US $)
2024-09-30 $431
2024-06-30 $425
2024-03-31 $440
2023-12-31 $448
2023-09-30 $452
2023-06-30 $459
2023-03-31 $463
2022-12-31 $470
2022-09-30 $470
2022-06-30 $484
2022-03-31 $501
2021-12-31 $514
2021-09-30 $460
2021-06-30 $468
2021-03-31 $471
2020-12-31 $478
2020-09-30 $462
2020-06-30 $461
2020-03-31 $468
2019-12-31 $478
2019-09-30 $491
2019-06-30 $508
2019-03-31 $514
2018-12-31 $544
2018-09-30 $567
2018-06-30 $569
2018-03-31 $123
2017-12-31 $487
2017-09-30 $223
2017-06-30 $232
2017-03-31 $240
2016-12-31 $233
2016-09-30 $228
2016-06-30 $223
2016-03-31 $219
2015-12-31 $214
2015-09-30 $206
2015-06-30 $215
2015-03-31 $216
2014-12-31 $188
2014-09-30 $191
2014-06-30 $194
2014-03-31 $190
2013-12-31 $188
2013-09-30 $180
2013-06-30 $179
2013-03-31 $177
2012-12-31 $181
2012-09-30 $171
2012-06-30 $137
2012-03-31 $127
2011-12-31 $118
2011-09-30 $115
2011-06-30 $111
2011-03-31 $109
2010-12-31 $106
2010-09-30 $103
2010-06-30 $103
2010-03-31 $102
2009-12-31 $102
2009-09-30 $96
2009-06-30 $96
2009-03-31 $96
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.401B $2.394B
Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories Inc., is based in New Jersey, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $73.775B 28.39
Chugai Pharmaceutical (CHGCY) Japan $70.198B 27.35
Takeda Pharmaceutical (TAK) Japan $41.396B 8.62
Merck (MKKGY) Germany $18.461B 16.53
Sandoz Group AG (SDZNY) Switzerland $18.159B 0.00
Astellas Pharma (ALPMY) Japan $17.463B 16.08
United Therapeutics (UTHR) United States $16.079B 15.82
Neurocrine Biosciences (NBIX) United States $13.664B 36.18
Summit Therapeutics (SMMT) United States $13.569B 0.00
Shionogi (SGIOY) Japan $11.688B 11.71
Madrigal Pharmaceuticals (MDGL) United States $6.399B 0.00
Orion OYJ (ORINY) Finland $6.196B 17.42
Ionis Pharmaceuticals (IONS) United States $5.620B 0.00
Corcept Therapeutics (CORT) United States $5.359B 40.60
Crinetics Pharmaceuticals (CRNX) United States $4.891B 0.00
PTC Therapeutics (PTCT) United States $3.490B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.560B 11.60
Dyne Therapeutics (DYN) United States $2.473B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.352B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.314B 0.00
Soleno Therapeutics (SLNO) United States $1.949B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.746B 0.00
Xencor (XNCR) United States $1.680B 0.00
Indivior (INDV) United States $1.591B 6.48
Evotec AG (EVO) Germany $1.559B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.531B 0.00
Guardian Pharmacy Services (GRDN) United States $1.382B 0.00
Ocular Therapeutix (OCUL) United States $1.328B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.294B 0.00
Harrow (HROW) United States $1.226B 0.00
Enliven Therapeutics (ELVN) United States $1.117B 0.00
Ardelyx (ARDX) United States $1.111B 0.00
ARS Pharmaceuticals (SPRY) United States $1.100B 0.00
Collegium Pharmaceutical (COLL) United States $0.982B 5.36
Avadel Pharmaceuticals (AVDL) Ireland $0.974B 0.00
Bioventus (BVS) United States $0.854B 26.97
Oruka Therapeutics (ORKA) United States $0.727B 0.00
Cronos Group (CRON) Canada $0.715B 0.00
Relay Therapeutics (RLAY) United States $0.713B 0.00
USANA Health Sciences (USNA) United States $0.662B 12.27
Ironwood Pharmaceuticals (IRWD) United States $0.621B 0.00
Elite Pharmaceuticals (ELTP) United States $0.609B 0.00
Altimmune (ALT) United States $0.582B 0.00
Savara (SVRA) United States $0.554B 0.00
Tourmaline Bio (TRML) United States $0.522B 0.00
Xeris Biopharma Holdings (XERS) United States $0.508B 0.00
OmniAb (OABI) United States $0.494B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.478B 0.00
Zevra Therapeutics (ZVRA) United States $0.456B 0.00
Verve Therapeutics (VERV) United States $0.437B 0.00
Siga Technologies (SIGA) United States $0.431B 5.03
Esperion Therapeutics (ESPR) United States $0.429B 0.00
ProKidney (PROK) United States $0.426B 0.00
Organogenesis (ORGO) United States $0.412B 0.00
Korro Bio (KRRO) United States $0.404B 0.00
KalVista Pharmaceuticals (KALV) United States $0.400B 0.00
Akebia Therapeutics (AKBA) United States $0.391B 0.00
Aquestive Therapeutics (AQST) United States $0.332B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.303B 122.93
Avita Medical (RCEL) United States $0.301B 0.00
Aldeyra Therapeutics (ALDX) United States $0.289B 0.00
Nature's Sunshine Products (NATR) United States $0.280B 16.63
Amylyx Pharmaceuticals (AMLX) United States $0.271B 0.00
4D Molecular Therapeutics (FDMT) United States $0.267B 0.00
Larimar Therapeutics (LRMR) United States $0.254B 0.00
Heron Therapeutics (HRTX) United States $0.233B 0.00
Innate Pharma SA (IPHYF) France $0.233B 0.00
Profound Medical (PROF) Canada $0.219B 0.00
Inhibikase Therapeutics (IKT) United States $0.212B 0.00
Acrivon Therapeutics (ACRV) United States $0.208B 0.00
Lexeo Therapeutics (LXEO) United States $0.200B 0.00
Aclaris Therapeutics (ACRS) United States $0.198B 0.00
Silence Therapeutics (SLN) United Kingdom $0.190B 0.00
Lyell Immunopharma (LYEL) United States $0.187B 0.00
MediWound (MDWD) Israel $0.186B 0.00
Nektar Therapeutics (NKTR) United States $0.174B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.162B 0.00
Nanobiotix S.A (NBTX) France $0.155B 0.00
CytoDyn (CYDY) United States $0.150B 0.00
Metagenomi (MGX) United States $0.144B 0.00
VAXART, INC (VXRT) United States $0.137B 0.00
Telomir Pharmaceuticals (TELO) United States $0.134B 0.00
Achieve Life Sciences (ACHV) Canada $0.131B 0.00
Galectin Therapeutics (GALT) United States $0.126B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.124B 0.00
Cassava Sciences (SAVA) United States $0.110B 0.00
Cardiol Therapeutics (CRDL) Canada $0.107B 0.00
Protara Therapeutics (TARA) United States $0.107B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.107B 0.00
Champions Oncology (CSBR) United States $0.104B 0.00
Regulus Therapeutics (RGLS) United States $0.102B 0.00
Inotiv (NOTV) United States $0.100B 0.00
Journey Medical (DERM) United States $0.097B 0.00
ElectroCore (ECOR) United States $0.095B 0.00
Avalo Therapeutics (AVTX) United States $0.094B 0.00
Pyxis Oncology (PYXS) United States $0.092B 0.00
Century Therapeutics (IPSC) United States $0.089B 0.00
Fractyl Health (GUTS) United States $0.088B 0.00
Karyopharm Therapeutics (KPTI) United States $0.082B 0.00
Context Therapeutics (CNTX) United States $0.082B 0.00
Assertio Holdings (ASRT) United States $0.080B 21.08
Arch Biopartners (ACHFF) Canada $0.078B 0.00
PMV Pharmaceuticals (PMVP) United States $0.078B 0.00
Unicycive Therapeutics (UNCY) United States $0.074B 0.00
ESSA Pharma (EPIX) Canada $0.071B 0.00
Vivani Medical (VANI) United States $0.070B 0.00
Scienture Holdings (SCNX) United States $0.070B 0.00
OptiNose (OPTN) United States $0.064B 0.00
Mural Oncology (MURA) Ireland $0.053B 0.00
AlloVir (ALVR) United States $0.052B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.050B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Iterum Therapeutics (ITRM) Ireland $0.048B 0.00
Nutriband (NTRB) United States $0.047B 0.00
Rafael Holdings (RFL) United States $0.044B 0.00
Gain Therapeutics (GANX) United States $0.042B 0.00
CASI Pharmaceuticals (CASI) China $0.042B 0.00
SCYNEXIS (SCYX) United States $0.038B 0.00
BioVie (BIVI) United States $0.037B 0.00
FibroGen (FGEN) United States $0.036B 0.00
VYNE Therapeutics (VYNE) United States $0.035B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.033B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.033B 0.00
Surrozen (SRZN) United States $0.032B 0.00
Incannex Healthcare (IXHL) Australia $0.031B 0.00
Tempest Therapeutics (TPST) United States $0.031B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.031B 0.00
DURECT (DRRX) United States $0.027B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Lipocine (LPCN) United States $0.025B 0.00
Vivos Therapeutics (VVOS) United States $0.023B 0.00
Mannatech (MTEX) United States $0.022B 0.00
Citius Pharmaceuticals (CTXR) United States $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.018B 0.00
NRx Pharmaceuticals (NRXP) United States $0.018B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
MEI Pharma (MEIP) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.015B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
GlycoMimetics (GLYC) United States $0.013B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Relmada Therapeutics (RLMD) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Klotho Neurosciences (KLTO) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Indaptus Therapeutics (INDP) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Viracta Therapeutics (VIRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Dominari Holdings (DOMH) United States $0.008B 0.00
Redhill Biopharma (RDHL) Israel $0.008B 0.00
CERo Therapeutics Holdings (CERO) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Conduit Pharmaceuticals (CDT) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Bio-Path Holdings (BPTH) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
Biomerica (BMRA) United States $0.004B 0.00
TNF Pharmaceuticals (TNFA) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.10
SHINECO (SISI) China $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Molecular Templates (MTEM) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Phio Pharmaceuticals (PHIO) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.001B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
Jupiter Neurosciences (JUNS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.69
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 41.84